Abstract
Purpose
Diffuse intrinsic pontine glioma (DIPG) is the most severe pediatric solid tumor, with no significant improvement in the past 50 years. Possible reasons for failure to make therapeutic progress include poor understanding of the underlying molecular biology due to lack of tumor material.
Methods
We performed a prospective analysis of children with typical appearance of DIPG who had a stereotactic biopsy in our unit since 2002. Technical approach, complications, histopathological results, and samples processing are exposed. The literature on this subject is discussed.
Results
Reviewing our own 130 cases of DIPG biopsies and previous published data, these procedures appear to have a diagnostic yield and morbidity rates similar to those reported for other brain locations (3.9 % of transient morbidity in our series). In addition, the quality and the quantity of the material obtained allow to (1) confirm the diagnosis, (2) reveal that WHO grading was useless to predict outcome, and (3) perform an extended molecular screen, including biomarkers study and the development of preclinical models. Recent studies reveal that DIPG may comprise more than one biological entity and a unique oncogenesis involving mutations never described in other types of cancers, i.e., histones H3 K27M and activin receptor ACVR1.
Conclusion
Stereotactic biopsies of DIPG can be considered as a safe procedure in well-trained neurosurgical teams and could be incorporated in protocols. It is a unique opportunity to integrate DIPG biopsies in clinical practice and use the biology at diagnosis to drive the introduction of innovative targeted therapies, in combination with radiotherapy.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ (2012) Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev 38:27–35. doi:10.1016/j.ctrv.2011.06.007
Warren KE, Killian K, Suuriniemi M, et al. (2012) Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro-Oncology 14:326–332. doi:10.1093/neuonc/nor190
Epstein F, Wisoff JH (1988) Intrinsic brainstem tumors in childhood: surgical indications. J Neuro-Oncol 6:309–317
Bax DA, Mackay A, Little SE, et al. (2010) A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin Cancer Res 16:3368–3377. doi:10.1158/1078-0432.CCR-10-0438
Paugh BS, Broniscer A, Qu C, et al. (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999–4006. doi:10.1200/JCO.2011.35.5677
Qu HQ, Jacob K, Fatet S, et al. (2010) Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas. Neuro-Oncology 12:153–163. doi:10.1093/neuonc/nop001
Zarghooni M, Bartels U, Lee E, et al. (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28:1337–1344. doi:10.1200/JCO.2009.25.5463
Roujeau T, Machado G, Garnett MR, et al. (2007) Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107:1–4. doi:10.3171/PED-07/07/001
Robison NJ, Kieran MW (2014) Diffuse intrinsic pontine glioma: a reassessment. J Neurooncol 119:7–15. doi:10.1007/s11060-014-1448-8
Puget S, Philippe C, Bax DA, et al. (2012) Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7:e30313. doi: 10.1371/journal.pone.0030313
Kieran MW (2015) Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). Pediatr Blood Cancer 62:3–4. doi:10.1002/pbc.25266
Gleason CA, Wise BL, Feinstein B (1978) Stereotactic localization (with computerized tomographic scanning), biopsy, and radiofrequency treatment of deep brain lesions. Neurosurgery 2:217–222
Epstein F, McCleary EL (1986) Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 64:11–15. doi:10.3171/jns.1986.64.1.0011
Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP (1986) Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 65:745–750. doi:10.3171/jns.1986.65.6.0745
Albright AL, Packer RJ, Zimmerman R, et al. (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029 discussion 1029–30
Chico-Ponce de Leon F, Perezpena-Diazconti M, Castro-Sierra E, et al. (2003) Stereotactically-guided biopsies of brainstem tumors. Childs Nerv Syst 19:305–310. doi:10.1007/s00381-003-0737-x
Dellaretti M, Touzet G, Reyns N, et al. (2011) Correlation among magnetic resonance imaging findings, prognostic factors for survival, and histological diagnosis of intrinsic brainstem lesions in children. J Neurosurg Pediatr 8:539–543. doi:10.3171/2011.9.PEDS1167
Leach PA, Estlin EJ, Coope DJ, et al. (2008) Diffuse brainstem gliomas in children: should we or shouldn’t we biopsy? Br J Neurosurg 22:619–624. doi:10.1080/02688690802366198
Pincus DW, Richter EO, Yachnis AT, et al. (2006) Brainstem stereotactic biopsy sampling in children. J Neurosurg 104:108–114. doi:10.3171/ped.2006.104.2.108
Rajshekhar V, Moorthy RK (2010) Status of stereotactic biopsy in children with brain stem masses: insights from a series of 106 patients. Stereotact Funct Neurosurg 88:360–366. doi:10.1159/000319044
St George EJ, Walsh AR, Sgouros S (2004) Stereotactic biopsy of brain tumours in the paediatric population. Childs Nerv Syst 20:163–167. doi:10.1007/s00381-003-0897-8
Valdes-Gorcia J, Espinoza-Diaz DM, Paredes-Diaz E (1998) Stereotactic biopsy of brain stem and posterior fossa lesions in children. Acta Neurochir 140:899–903
Puget S, Blauwblomme T, Grill J (2012) Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma? Am Soc Clin Oncol Educ Book 629–633. doi: 10.14694/EdBook_AM.2012.32.629
Hankinson TC, Campagna EJ, Foreman NK, Handler MH (2011) Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. J Neurosurg Pediatr 8:97–102. doi:10.3171/2011.4.PEDS1180
Sufit A, Donson AM, Birks DK, et al. (2012) Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas. J Neurosurg Pediatr 10:81–88. doi:10.3171/2012.3.PEDS11316
Samadani U, Judy KD (2003) Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereotact Funct Neurosurg 81:5–9. doi:10.1159/000075097
Wang ZJ, Rao L, Bhambhani K, et al. (2015) Diffuse intrinsic pontine glioma biopsy: a single institution experience. Pediatr Blood Cancer 62:163–165. doi:10.1002/pbc.25224
McGirt MJ, Woodworth GF, Coon AL, et al. (2005) Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102:897–901. doi:10.3171/jns.2005.102.5.0897
Geoerger B, Hargrave D, Thomas F, et al. (2011) Innovative therapies for children with cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. Neuro-Oncology 13:109–118. doi:10.1093/neuonc/noq141
Buczkowicz P, Hoeman C, Rakopoulos P, et al. (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451–456. doi:10.1038/ng.2936
Grill J, Puget S, Andreiuolo F, et al. (2012) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 58:489–491. doi:10.1002/pbc.24060
Backlund EO (1971) A new instrument for stereotaxic brain tumour biopsy. Technical note. Acta Chir Scand 137:825–827
Dellaretti M, Reyns N, Touzet G, et al. (2012) Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90:79–83. doi:10.1159/000335502
Khatua S, Moore KR, Vats TS, Kestle JR (2011) Diffuse intrinsic pontine glioma—current status and future strategies. Childs Nerv Syst 27:1391–1397. doi:10.1007/s00381-011-1468-z
Wilkinson R, Harris J (2008) Moral and legal reasons for altruism in the case of brainstem biopsy in diffuse glioma. Br J Neurosurg 22:617–618. doi:10.1080/02688690802482896
Thirant C, Bessette B, Varlet P, et al. (2011) Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors. PLoS One 6:e16375. doi: 10.1371/journal.pone.0016375
Taylor KR, Mackay A, Truffaux N, et al. (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46:457–461. doi:10.1038/ng.2925
Wu G, Broniscer A, McEachron TA, et al. (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251–253. doi:10.1038/ng.1102
Bender S, Tang Y, Lindroth AM, et al. (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672. doi:10.1016/j.ccr.2013.10.006
Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, et al. (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46:462–466. doi:10.1038/ng.2950
Paugh BS, Zhu X, Qu C, et al. (2013) Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 73:6219–6229. doi:10.1158/0008-5472.CAN-13-1491
Wu G, Diaz AK, Paugh BS, et al. (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444–450. doi:10.1038/ng.2938
Khuong-Quang DA, Buczkowicz P, Rakopoulos P, et al. (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439–447. doi:10.1007/s00401-012-0998-0
Monje M, Mitra SS, Freret ME, et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A 108:4453–4458. doi: 10.1073/pnas.1101657108
Veringa SJ, Biesmans D, van Vuurden DG, et al. (2013) In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma. PLoS One 8:e61512. doi: 10.1371/journal.pone.0061512
Bartels U, Hawkins C, Vezina G, et al. (2011) Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. J Neurooncol 105:119–125. doi:10.1007/s11060-011-0704-4
Acknowledgments
We thank the Tumorotheque Necker-Enfants Malades and the CRB-ADN (Imagine, AP-HP, Université Paris Descartes).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puget, S., Beccaria, K., Blauwblomme, T. et al. Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst 31, 1773–1780 (2015). https://doi.org/10.1007/s00381-015-2832-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2832-1